Loading...
Loading...
Among the 2 tracked institutional investors we monitor, KAPA (KAIROS PHARMA LTD) is held with a combined value of $107.07K across 155,928 shares. The largest holder is VANGUARD GROUP INC with a position worth $93.60K (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund reduced its position.
Total Institutional Value
$107.07K
Total Shares Held
155,928
Institutional Holders
2
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $93.60K | 0.00% | New |
| 2 | STATE STREET CORP | $13.47K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of KAPA with a position worth $93.60K, representing 0.00% of their portfolio. In total, 2 institutional investors hold KAPA with a combined value of $107.07K.
In the most recent quarter, 1 fund opened a new position in KAPA. Additionally, 1 reduced their positions.
Institutional investors hold $107.07K worth of KAPA stock across 2 positions. The largest institutional holder is VANGUARD GROUP INC with $93.60K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For KAPA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their KAPA positions.